1102871

Naveed Razzaque, MD — FEI 3015651362

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgeton, MO (United States)

Additional Details

Clinical Investigator (CI)